Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
C.1.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
AY.91 (Delta)ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AY.91 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.91 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.91 (Delta)NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.39ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.39ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.39ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.39NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.617ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.617ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.617ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.617NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-16719.1US
B.1.1.383ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.383ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.383ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.383NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.40ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.40ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.40ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.40NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
AY.95 (Delta)ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AY.95 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.95 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.95 (Delta)NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.189ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.189ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.189ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.189NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.1.13ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.1.13ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.1.13ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.1.13NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
C.13ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
C.13ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-4083.33China
C.13ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
C.13NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
C.4ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
C.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
C.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
C.4NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.545ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.545ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.545ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.545NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.482ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used